A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

BACKGROUND: Lisdexamfetamine dimesylate (LDX) is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children 6 to 12 years of age and in adults. In a previous laboratory school study, LDX demonstrated efficacy 2 hours postdose with duration of efficacy through 12 hours...

Full description

Saved in:
Bibliographic Details
Main Authors: Wigal, Sharon B, Kollins, Scott H, Childress, Ann C, Squires, Liza
Format: Artigo
Language:Inglês
Published: BioMed Central 2009
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704174/
https://ncbi.nlm.nih.gov/pubmed/19508731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1753-2000-3-17
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items